How do you pay?

How to pay the least

Ask for the cash price

Soltamox

Sold only in a different form, strength or formula. Switching to one would need a new prescription, so ask your prescriber whether it could work for you.

  1. Ask your pharmacy for Soltamox’s cash price, and one or two other pharmacies too.
  2. Soltamox’s savings card works only with insurance from a job or one you bought.

Compare every option

Question
Brand nameSoltamox
Authorized generictamoxifen
Regular generictamoxifen
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Other forms onlyAsk your doctor
Same as Soltamox?
The original
–
–

Brand nameThe maker’s card

SOLTAMOX Mayne Pharma Patient Savings Card

Savings card from Mayne Pharma

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a prescription

Sign up on soltamox.com 

In the maker’s words

“Most covered, insured, eligible patients may pay as little as $0 for their SOLTAMOX prescription.”

From the maker’s offer on soltamox.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Soltamox itself, from the same company, sold without the brand name, and usually for less. For now Soltamox is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Sold only in a different form, strength or formula. Switching to one would need a new prescription, so ask your prescriber whether it could work for you. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

SOLTAMOX is an estrogen agonist/antagonist indicated:

  • For treatment of adult patients with estrogen receptor-positive metastatic breast cancer
  • For adjuvant treatment of adult patients with early stage estrogen receptor- positive breast cancer
  • To reduce risk of invasive breast cancer following breast surgery and radiation in adult women with ductal carcinoma in situ (DCIS)
  • To reduce the incidence of breast cancer in adult women at high risk

Source: the FDA label for Soltamox (Mayne Pharma), November 29, 2021. Full label on DailyMed 

Good to know